Nextbio Holdings Overview
- Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
93
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
Nextbio Holdings General Information
Description
Joongang Dnm Co Ltd, formerly Centralbio Co Ltd provides all the harmfulness, environmental hazard, and physico-chemical characteristic tests. The various tests provided by the company include Genotoxicity test, Antigenicity test, Immunotoxicity test, Dependency test and Carcinogenicity test among others.
Contact Information
Formerly Known As
HULIMS Co., Ltd., SNH
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Electronics (B2C)
Other Industries
Other Consumer Durables
Acquirer
Former Stock Listing
051980
Primary Office
- B-2226 Hakeuiro
- Dongangu
- Anyang, 014-056
- South Korea
Nextbio Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nextbio Holdings Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Nextbio Holdings Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|